H.R.8324

H. R. 8324

April 16, 2026

Mr. Burlison (for himself and Mr. Barrett) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, the Judiciary, Armed Services, Veterans' Affairs, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Internal Revenue Code of 1986 to increase the limitations on contributions to health savings accounts, to amend the Public Health Service Act to provide for hospital and insurer price transparency, and for other purposes.

1. Short title; table of contents; TITLE I—HEALTH SAVINGS ACCOUNTS; 101. Short title; 102. Increase in contribution limitations; 103. Freedom from mandate; 104. Amounts paid for health insurance or direct primary care service arrangement; 105. Special rule for certain medical expenses incurred before establishment of account; 106. Administrative error correction before due date of return; 107. Allowing HSA rollover to child or parent of account holder; 108. Coverage for amounts paid for healthy food, vitamins, dietary supplements, and sports and fitness expenses; 109. Equivalent bankruptcy protections for health savings accounts as retirement funds; 110. Satisfaction of employer mandate through health savings account contributions; 111. Rollovers from health care FSAs and HRAs permitted; 112. Qualified general contributions to health savings accounts; 113. Charitable contributions to health savings accounts; 114. Amounts paid for health care sharing ministry; TITLE II—HEALTH MARKETPLACE FOR ALL; 201. Short title; 202. Health marketplace pools deemed an “employer” for purposes of offering group health plans or group health insurance coverage; 203. Conforming amendments; TITLE III—STRENGTHENING HOSPITAL AND INSURER PRICE TRANSPARENCY; 301. Short title; 302. Strengthening hospital price transparency requirements; 303. Increasing price transparency of clinical diagnostic laboratory tests; 304. Imaging transparency; 305. Ambulatory surgical center price transparency requirements; 306. Strengthening health coverage transparency requirements; 307. Increasing group health plan access to health data; 308. Oversight of administrative service providers; 309. State preemption only in event of conflict; 310. Requirement for explanation of benefits; 311. Provision of itemized bills; TITLE IV—PROTECTING PATIENT ACCESS TO CANCER AND COMPLEX THERAPIES; 401. Short title; 402. Rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation; TITLE V—EXPANDED-ACCESS PRESCRIPTION DRUGS; 501. Expanded-access prescription drugs; 502. Government sponsored programs